Amp 2024 Usfk. The accelerating medicines partnership® (amp®) program was launched in february 2014 to bring together the resources and expertise of both the national institutes of health (nih) and the private sector to solve pressing challenges in various diseases and disease areas. All participants at the amp 2024 annual meeting & expo are invited to submit abstracts of original studies related to molecular pathology and diagnostics.

Expo is the only opportunity to connect historically with key decision makers involved in every aspect of molecular diagnostics, including:. Access to the keynote lecture by the amp award for excellence in molecular diagnostics recipient.